LXR Alpha Restricts Gammaherpesvirus Reactivation from Latently Infected Peritoneal Cells.

ABSTRACT: Gammaherpesviruses are ubiquitous viruses that establish lifelong infections. Importantly, these viruses are associated with numerous cancers and lymphoproliferative diseases. While risk factors for developing gammaherpesvirus-driven cancers are poorly understood, it is clear that elevated viral reactivation from latency often precedes oncogenesis. Here, we demonstrate that the liver X receptor alpha isoform (LXR?) restricts gammaherpesvirus reactivation in an anatomic-site-specific manner. We have previously demonstrated that deficiency of both LXR isoforms (? and ?) leads to an increase in fatty acid and cholesterol synthesis in primary macrophage cultures, with a corresponding increase in gammaherpesvirus replication. Interestingly, expression of fatty acid synthesis genes was not derepressed in LXR?-deficient hosts, indicating that the antiviral effects of LXR? are independent of lipogenesis. Additionally, the critical host defenses against gammaherpesvirus reactivation, virus-specific CD8⁺ T cells and interferon (IFN) signaling, remained intact in the absence of LXR?. Remarkably, using a murine gammaherpesvirus 68 (MHV68) reporter virus, we discovered that LXR? expression dictates the cellular tropism of MHV68 in the peritoneal cavity. Specifically, LXR?^-/- mice exhibit reduced latency within the peritoneal B cell compartment and elevated latency within F4/80⁺ cells. Thus, LXR? restricts gammaherpesvirus reactivation through a novel mechanism that is independent of the known CD8⁺ T cell-based antiviral responses or changes in lipid synthesis and likely involves changes in the tropism of MHV68 in the peritoneal cavity.IMPORTANCE Liver X receptors (LXRs) are nuclear receptors that mediate cholesterol and fatty acid homeostasis. Importantly, as ligand-activated transcription factors, LXRs represent potential targets for the treatment of hypercholesterolemia and atherosclerosis. Here, we demonstrate that LXR?, one of the two LXR isoforms, restricts reactivation of latent gammaherpesvirus from peritoneal cells. As gammaherpesviruses are ubiquitous oncogenic agents, LXRs may represent a targetable host factor for the treatment of poorly controlled gammaherpesvirus infection and associated lymphomagenesis.

SUBMITTER: Lange PT 

PROVIDER: S-EPMC6401431 | biostudies-literature | 2019 Mar

REPOSITORIES: biostudies-literature